Sanofi's Sarclisa cuts death risk in mutiple myeloma
admin 12th May 2020 Uncategorised 0The Phase III IKEMA trial hit its primary endpoint
More: Sanofi's Sarclisa cuts death risk in mutiple myeloma
Source: News
The Phase III IKEMA trial hit its primary endpoint
More: Sanofi's Sarclisa cuts death risk in mutiple myeloma
Source: News
© 1994 - 2026 B.M. Pharmaceuticals